CGI PHARMACEUTICALS
Founded out of Yale University, CGI (formerly Cellular Genomics Inc.) began operations in 2000. CGI, in conjunction with several biotech and pharmaceutical partners (Pfizer, Serono, Lilly, Affymetrix, and Schering AG), utilized a unique chemical-genetics approach known as “ASKA” (Analog Sensitive Kinase Alleles) to understand kinase function. CGI Pharmaceuticals is dedicated to the discovery and development of breakthrough small molecule therapeutics for a broad range of oncology and al... lergy/autoimmune/inflammatory disease (AAID) indications. The Company’s fully integrated drug discovery infrastructure comprises proprietary kinase biology and chemistry, extensive lead generation and optimization capabilities, as well as drug metabolism/pharmacokinetics (DMPK) expertise. Utilizing its comprehensive chemistry capabilities, CGI has generated a proprietary small molecule kinase inhibitor library of over 50,000 compounds (all compounds designed and synthesized by CGI). To date, CGI has been awarded 8 U.S. patents covering its novel collection of kinase inhibitors. Moreover, all three of CGI’s drug discovery and development programs are based on hits obtained from CGI’s library.
CGI PHARMACEUTICALS
Industry:
Biotechnology Genetics Health Care Pharmaceutical
Founded:
1998-01-01
Address:
Branford, Connecticut, United States
Country:
United States
Website Url:
http://www.cgipharma.com
Total Employee:
11+
Status:
Closed
Contact:
(203) 315-1222
Email Addresses:
[email protected]
Total Funding:
44.3 M USD
Technology used in webpage:
SPF SSL By Default Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Sectigo SSL Sectigo Domain SSL Zoom Video Conferencing Zoom Proofpoint
Current Advisors List
Current Employees Featured
Founder
Investors List
Lilly Ventures
Lilly Ventures investment in Series C - CGI Pharmaceuticals
Connecticut Innovations
Connecticut Innovations investment in Series C - CGI Pharmaceuticals
Vector Fund Management
Vector Fund Management investment in Series C - CGI Pharmaceuticals
MPM Capital
MPM Capital investment in Series C - CGI Pharmaceuticals
Coastview Capital
Coastview Capital investment in Series C - CGI Pharmaceuticals
Flagship Pioneering
Flagship Pioneering investment in Series C - CGI Pharmaceuticals
Emerging Technology Partners
Emerging Technology Partners investment in Series C - CGI Pharmaceuticals
